Award recordCONTRACT

ARIAD PHARMACEUTICALS, INC.

PIID VA26017J3080· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6810 · CHEMICALS· FY2017· $79,221 net obligations· UEI EVMMLCKBZS47· MA

Description

CLOSEOUT ICLUSIG (POTATINIB) 15MG TABLET

Base award description: BULK FUNDED PHARMACY ORDER : ICLUSIG (POTATINIB) 15MG TABLET

First action · last action
2016-10-01 · 2018-01-10
Transactions
3
First transaction's obligation
$205,544
Base + all options value (sum of deltas)
$79,221
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P15A0016
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$205,544$0Base award · 2016-10-01 · this action $205,544 · running total $205,544Modification P00001 · 2017-08-08 · this action -$107,961 · running total $97,583Modification P00002 · 2018-01-10 · this action -$18,361 · running total $79,221
  • Base2016-10-01+$205,544= $205,544
  • Mod P000012017-08-08-$107,961= $97,583
  • Mod P000022018-01-10-$18,361= $79,221
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-01+$205,544$205,544BULK FUNDED PHARMACY ORDER : ICLUSIG (POTATINIB) 15MG TABLET
Mod P00001· FUNDING ONLY ACTION2017-08-08−$107,961$97,583BULK FUNDED PHARMACY ORDER : ICLUSIG (POTATINIB) 15MG TABLET
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-01-10−$18,361$79,221CLOSEOUT ICLUSIG (POTATINIB) 15MG TABLET

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EVMMLCKBZS47)

AwardOffice · PSC / listingNet obligationsFY
36C25219F0494252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919N0606249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$23,004FY2019
36C25219F0450252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919F0373249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$11,502FY2019
36C24519F0682245-NETWORK CONTRACT OFFICE 5 (36C245) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$0FY2019
36C25219F0412252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019

Other recipients under 6810 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26018P3900LIFE CHEMICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$80,976FY2018
VA26018P2530BSE PERFORMANCE, LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$24,960FY2018
VA26017F0129UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20 (36C260)$91,147FY2017
VA26016F1444LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$6,829FY2016
VA26016P1112MCKESSON CORPORATION260-NETWORK CONTRACT OFFICE 20 (36C260)$112,285FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26017J3080_3600_VA797P15A0016_3600 · retrieved 2026-09-26.